Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer

We examined the potential of quantitative epidermal growth factor receptor (EGFR, synonym: c-erbB-1) and c-erbB-2 (synonym: HER2/neu) mRNA expression to predict minor or major histopathologic response to neoadjuvant radiochemotherapy (cis-platinum, 5-FU, 36 Gy), followed by radical surgical resectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazono, F, Metzger, R, Warnecke-Eberz, U, Baldus, S E, Brabender, J, Bollschweiler, E, Doerfler, W, Mueller, R P, Dienes, H P, Aikou, T, Hoelscher, A H, Schneider, P M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364782/
https://www.ncbi.nlm.nih.gov/pubmed/15213712
http://dx.doi.org/10.1038/sj.bjc.6601976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364782/
https://www.ncbi.nlm.nih.gov/pubmed/15213712
http://dx.doi.org/10.1038/sj.bjc.6601976

Ejemplares similares